Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Oct 4;10(10):CD001892.
doi: 10.1002/14651858.CD001892.pub4.

Low protein diets for non-diabetic adults with chronic kidney disease

Deirdre Hahn  1 , Elisabeth M Hodson, Denis Fouque
Affiliations
Meta-Analysis

Low protein diets for non-diabetic adults with chronic kidney disease

Deirdre Hahn et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Chronic kidney disease (CKD) is defined as reduced function of the kidneys present for 3 months or longer with adverse implications for health and survival. For several decades low protein diets have been proposed for participants with CKD with the aim of slowing the progression to end-stage kidney disease (ESKD) and delaying the onset of renal replacement therapy. However the relative benefits and harms of dietary protein restriction for preventing progression of CKD have not been resolved. This is an update of a systematic review first published in 2000 and updated in 2006 and 2009.

Objectives: To determine the efficacy of low protein diets in preventing the natural progression of CKD towards ESKD and in delaying the need for commencing dialysis treatment in non-diabetic adults.

Search methods: We searched the Cochrane Kidney and Transplant Register of Studies up to 2 March 2018 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.

Selection criteria: We included randomised controlled trials (RCTs) or quasi RCTs in which adults with non-diabetic chronic kidney disease (stages 3 to 5) not on dialysis were randomised to receive a very low protein intake (0.3 to 0.4 g/kg/d) compared with a low protein intake (0.5 to 0.6 g/kg/d) or a low protein intake compared with a normal protein intake (≥ 0.8 g/kg/d) for 12 months or more.

Data collection and analysis: Two authors independently selected studies and extracted data. For dichotomous outcomes (death, all causes), requirement for dialysis, adverse effects) the risk ratios (RR) with 95% confidence intervals (CI) were calculated and summary statistics estimated using the random effects model. Where continuous scales of measurement were used (glomerular filtration rate (GFR), weight), these data were analysed as the mean difference (MD) or standardised mean difference (SMD) if different scales had been used. The certainty of the evidence was assessed using GRADE.

Main results: We identified an additional six studies to include 17 studies with 2996 analysed participants (range 19 to 840). Four larger multicentre studies were subdivided according to interventions so that the review included 21 separate data sets. Mean duration of participant follow-up ranged from 12 to 50 months.Random sequence generation and allocation concealment were considered at low risk of bias in eleven and nine studies respectively. All studies were considered at high risk for performance bias as they were open-label studies. We assessed detection bias for outcome assessment for GFR and ESKD separately. As GFR measurement was a laboratory outcome all studies were assessed at low risk of detection bias. For ESKD, nine studies were at low risk of detection bias as the need to commence dialysis was determined by personnel independent of the study investigators. Five studies were assessed at high risk of attrition bias with eleven studies at low risk. Ten studies were at high risk for reporting bias as they did not include data which could be included in a meta-analysis. Eight studies reported funding from government bodies while the remainder did not report on funding.Ten studies compared a low protein diet with a normal protein diet in participants with CKD categories 3a and b (9 studies) or 4 (one study). There was probably little or no difference in the numbers of participants who died (5 studies 1680 participants: RR 0.77, 95% CI 0.51 to 1.18; 13 fewer deaths per 1000; moderate certainty evidence). A low protein diet may make little or no difference in the number of participants who reached ESKD compared with a normal protein diet (6 studies, 1814 participants: RR 1.05, 95% CI 0.73 to 1.53; 7 more per 1000 reached ESKD; low certainty evidence). It remains uncertain whether a low protein diet compared with a normal protein intake impacts on the outcome of final or change in GFR (8 studies, 1680 participants: SMD -0.18, 95% CI -0.75 to 0.38; very low certainty evidence).Eight studies compared a very low protein diet with a low protein diet and two studies compared a very low protein diet with a normal protein diet. A very low protein intake compared with a low protein intake probably made little or no difference to death (6 studies, 681 participants: RR 1.26, 95% CI 0.62 to 2.54; 10 more deaths per 1000; moderate certainty evidence). However it probably reduces the number who reach ESKD (10 studies, 1010 participants: RR 0.65, 95% CI 0.49 to 0.85; 165 per 1000 fewer reached ESKD; moderate certainty evidence). It remains uncertain whether a very low protein diet compared with a low or normal protein intake influences the final or change in GFR (6 studies, 456 participants: SMD 0.12, 95% CI -0.27 to 0.52; very low certainty evidence).Final body weight was reported in only three studies. It is uncertain whether the intervention alters final body weight (3 studies, 89 participants: MD -0.40 kg, 95% CI -6.33 to 5.52; very low certainty evidence).Twelve studies reported no evidence of protein energy wasting (malnutrition) in their study participants while three studies reported small numbers of participants in each group with protein energy wasting. Most studies reported that adherence to diet was satisfactory. Quality of life was not formally assessed in any studies.

Authors' conclusions: This review found that very low protein diets probably reduce the number of people with CKD 4 or 5, who progress to ESKD. In contrast low protein diets may make little difference to the number of people who progress to ESKD. Low or very low protein diets probably do not influence death. However there are limited data on adverse effects such as weight differences and protein energy wasting. There are no data on whether quality of life is impacted by difficulties in adhering to protein restriction. Studies evaluating the adverse effects and the impact on quality of life of dietary protein restriction are required before these dietary approaches can be recommended for widespread use.

PubMed Disclaimer

Conflict of interest statement

Professor Denis Fouque has received lecture fees for nutrition in renal disease.

Figures

1
1
Study flow diagram
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Low protein diet versus normal protein diet, Outcome 1 Death (all causes).
1.2
1.2. Analysis
Comparison 1 Low protein diet versus normal protein diet, Outcome 2 ESKD.
1.3
1.3. Analysis
Comparison 1 Low protein diet versus normal protein diet, Outcome 3 End or change in GFR.
2.1
2.1. Analysis
Comparison 2 Very low protein diet versus low or normal protein diet, Outcome 1 Death (all causes).
2.2
2.2. Analysis
Comparison 2 Very low protein diet versus low or normal protein diet, Outcome 2 ESKD.
2.3
2.3. Analysis
Comparison 2 Very low protein diet versus low or normal protein diet, Outcome 3 End or change in GFR.
3.1
3.1. Analysis
Comparison 3 Nutritional measures, Outcome 1 Final body weight.
3.2
3.2. Analysis
Comparison 3 Nutritional measures, Outcome 2 Protein energy wasting.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Anonymous Study 1 1990 {published data only}
    1. European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology 1990;81:61‐70. [MEDLINE: ] - PubMed
    1. European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology 1992;98:133‐41. [MEDLINE: ] - PubMed
Anonymous Study 2 1990 {published data only}
    1. European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology 1990;81:61‐70. [MEDLINE: ] - PubMed
    1. European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology 1992;98:133‐41. [MEDLINE: ] - PubMed
Bergstrom 1986 {published data only}
    1. Alvestrand A, Bucht H, Gutierrez A, Bergström J. Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow‐ups [abstract]. Kidney International 1985;27(1):240.
    1. Bergstrom J, Alvestrand A, Bucht H, Gutierrez A. Progression of chronic renal failure in man is retarded with more frequent clinical follow‐ups and better blood pressure control. Clinical Nephrology 1986;25(1):1‐6. [MEDLINE: ] - PubMed
    1. Bergstrom J, Alvestrand A, Bucht H, Gutierrez A. Stockholm clinical study on progression of chronic renal failure‐‐an interim report. Kidney International ‐ Supplement 1989;36(Suppl 27):S110‐4. [MEDLINE: ] - PubMed
    1. Bergstrom J, Alvestrand A, Bucht H, Gutierrez A. What is the role of controls in an outpatient department on progression of renal disease?. Blood Purification 1988;6(6):336‐42. [MEDLINE: ] - PubMed
Chauveau 1986 {published data only}
    1. Chauveau P, Lebkiri B, Ployard F, Ciancioni C, Man NK, Jungers P. Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie 1986;7(5):137‐42. [MEDLINE: ] - PubMed
    1. Jungers P, Chauveau P, Ployard F, Lebkiri B, Ciancioni C, Man NK. Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International ‐ Supplement 1987;22:S67‐71. [MEDLINE: ] - PubMed
Cianciaruso 2008a {published data only}
    1. Cianciaruso B, Pota A, Bellizzi V, Giuseppe D, Micco L, Minutolo R, et al. Effect of a low‐ versus moderate‐protein diet on progression of CKD: follow‐up of a randomized controlled trial. American Journal of Kidney Diseases 2009;54(6):1052‐61. [MEDLINE: ] - PubMed
    1. Cianciaruso B, Pota A, Pisani A, Torraca S, Annecchini R, Lombardi P, et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4‐5‐‐a randomized controlled trial. Nephrology Dialysis Transplantation 2008;23(2):636‐44. [MEDLINE: ] - PubMed
    1. Cianciaruso B, Pota A, Torraca S, Somma G, Nazzaro P, Annecchini R, et al. Comparison of two different protein intakes (0.3‐0.6 vs 0.7‐0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15‐18; Lisbon, Portugal. 2004:295.
    1. Pota A, Pisani A, Annecchini R, Giuseppe D, Cuccurullo P, Caputo DL, et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv401.
    1. Pota A, Pisani A, Ravani P, Micco L, Giuseppe D, Sabbatini M, et al. Impact of two different low protein diets on survival of CKD patients (stage4‐5) [abstract no: TH‐PO880]. Journal of the American Society of Nephrology 2008;19(Abstracts Issue):308A.
Di Iorio 2003 {published data only}
    1. Iorio BR, Bellizzi V, Minutolo R, Nicola L, Iodice C, Conte G. Supplemented very low‐protein diet in advanced CRF: is it money saving?. Kidney International 2004;65(2):742. [MEDLINE: ] - PubMed
    1. Iorio BR, Minutolo R, Nicola L, Bellizzi V, Catapano F, Iodice C, et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International 2003;64(5):1822‐8. [MEDLINE: ] - PubMed
Garneata 2013 {published data only}
    1. Garneata L, Mircescu G. Effect of low‐protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition 2013;23(3):210‐3. [MEDLINE: ] - PubMed
    1. Garneata L, Stancu A, Dragomir D, Mircescu G. Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation 2014;29(Suppl 3):iii39. [EMBASE: 71491557]
    1. Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G. Ketoanalogue‐supplemented vegetarian very low‐protein diet and CKD progression. Journal of the American Society of Nephrology 2016;27(7):2164‐76. [MEDLINE: ] - PMC - PubMed
Ihle 1989 {published data only}
    1. Becker GJ, Whitworth JA, Ihle BU, Shahinfar S, Kincaid‐Smith PS. Prevention of progression in non‐diabetic chronic renal failure. Kidney International ‐ Supplement 1994;45(Suppl 45):S167‐70. [MEDLINE: ] - PubMed
    1. Ihle BU, Becker GJ, Whithworth JA, Charlwood RA, Kincaid‐Smith PS. The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine 1989;321(26):1773‐7. [MEDLINE: ] - PubMed
Locatelli 1989 {published data only}
    1. D'Amico G, Gentile MG, Fellin G, Manna G, Cofano F. Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation 1994;9(11):1590‐4. [MEDLINE: ] - PubMed
    1. Locatelli F. Controlled study of protein‐restricted diet in chronic renal failure. Contributions to Nephrology 1989;75:141‐6. [MEDLINE: ] - PubMed
    1. Locatelli F. Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology 1990;81:102‐6. [MEDLINE: ] - PubMed
    1. Locatelli F, Alberti D, Gentile MG, Graziani G, Buccianti G, Cosci P, et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. 10th International Congress of Nephrology; 1987 Jul 26‐31; London, UK. 1987:20.
    1. Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A. Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet 1991;337(8753):1299‐304. [MEDLINE: ] - PubMed
Malvy 1999 {published data only}
    1. Malvy D, Maingourd C, Pengloan J, Bagros P, Nivet H. Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition 1999;18(5):481‐6. [MEDLINE: ] - PubMed
    1. Nivet H, Maingourd C, Malvy D, Pengloan J, Bagros PH. Effects of severe protein‐restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology 1992;3(3):286. - PubMed
MDRD Feasibility Study A 1989 {published data only}
    1. The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases 1992;20(1):18‐33. [MEDLINE: ] - PubMed
    1. Coggins CH, Dwyer JT, Greene T, Petot G, Snetselaar LG, Lente F, et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases 1994;23(4):514‐23. [MEDLINE: ] - PubMed
    1. Klahr S, Levey AS, Sandberg AM, Williams GW, MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International 1989;35(1):195.
    1. Kopple JD, Berg R, Houser H, Steinman TI, Teschan P. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International ‐ Supplement 1989;27:S184‐94. [MEDLINE: ] - PubMed
    1. Laidlaw SA, Berg RL, Kopple JD, Naito H, Walker WG, Walser M. Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases 1994;23(4):504‐13. [MEDLINE: ] - PubMed
MDRD Feasibility Study B 1989 {published data only}
    1. The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases 1992;20(1):18‐33. [MEDLINE: ] - PubMed
    1. Coggins CH, Dwyer JT, Greene T, Petot G, Snetselaar LG, Lente F, et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases 1994;23(4):514‐23. [MEDLINE: ] - PubMed
    1. Klahr S, Levey AS, Sandberg AM, Williams GW, MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International 1989;35(1):195.
    1. Kopple JD, Berg R, Houser H, Steinman TI, Teschan P. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International ‐ Supplement 1989;27:S184‐94. [MEDLINE: ] - PubMed
    1. Laidlaw SA, Berg RL, Kopple JD, Naito H, Walker WG, Walser M. Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases 1994;23(4):504‐13. [MEDLINE: ] - PubMed
MDRD Study 1 1989 {published data only}
    1. Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology 1996;7(4):556‐66. [MEDLINE: ] - PubMed
    1. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology 1996;7(12):2616‐26. [MEDLINE: ] - PubMed
    1. Short‐term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology 1996;7(10):2097‐109. [MEDLINE: ] - PubMed
    1. The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases 1992;20(1):18‐33. [MEDLINE: ] - PubMed
    1. Beck GJ, Berg RL, Coggins CH, Gassman JJ, Hunsicker LG, Schluchter MD, et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials 1991;12(5):566‐86. [MEDLINE: ] - PubMed
MDRD Study 2 1989 {published data only}
    1. Klahr S. The modification of diet in renal disease study. New England Journal of Medicine 1989;320(13):864‐6. [MEDLINE: ] - PubMed
    1. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases 1996;27(5):652‐63. [MEDLINE: ] - PubMed
    1. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology 1999;10(11):2426‐39. [MEDLINE: ] - PubMed
Meloni 2004 {published data only}
    1. Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, Tozzo C, et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition 2004;14(4):208‐13. [MEDLINE: ] - PubMed
Milovanov 2009 {published data only}
    1. Milovanov IuS, Lysenko LV, Milovanova LI, Dobrosmyslov IA. The role of balanced low‐protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases. Terapevticheskii Arkhiv 2009;81(8):52‐7. [MEDLINE: ] - PubMed
Mircescu 2007 {published data only}
    1. Mircescu G, Garneata L, Stancu SH, Capusa C. Effects of a supplemented hypoproteic diet in chronic kidney disease. Journal of Renal Nutrition 2007;17(3):179‐88. [MEDLINE: ] - PubMed
Rosman Study 1 1984 {published data only}
    1. Bock HA, Brunner FP. Dietary protein restriction in chronic renal failure. Lancet 1985;1(8426):465‐6. [MEDLINE: ] - PubMed
    1. Donker AJ, Piers‐Becht TP. Four‐years follow‐up of patients with chronic renal insufficiency randomly allocated to a protein‐restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation 1989;4(5):455.
    1. Donker AJ, Rosman JB, Piers‐Becht TP, Sluiter WJ. Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International 1985;27:137.
    1. Rosman JB, Donker AJ. The response to a low‐protein diet to retard the progression of renal failure is sex‐dependent [abstract]. Nephrology Dialysis Transplantation 1989;4(5):457.
    1. Rosman JB, Donker AJ, Meijer S, Sluiter WJ, Piers‐Becht TP, Hem GK. Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology 1986;53:109‐20. [MEDLINE: ] - PubMed
Rosman Study 2 1984 {published data only}
    1. Bock HA, Brunner FP. Dietary protein restriction in chronic renal failure. Lancet 1985;1(8426):465‐6. [MEDLINE: ] - PubMed
    1. Donker AJ, Piers‐Becht TP. Four‐years follow‐up of patients with chronic renal insufficiency randomly allocated to a protein‐restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation 1989;4(5):455.
    1. Donker AJ, Rosman JB, Piers‐Becht TP, Sluiter WJ. Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International 1985;27:137.
    1. Rosman JB, Donker AJ. The response to a low‐protein diet to retard the progression of renal failure is sex‐dependent [abstract]. Nephrology Dialysis Transplantation 1989;4(5):457.
    1. Rosman JB, Donker AJ, Meijer S, Sluiter WJ, Piers‐Becht TP, Hem GK. Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology 1986;53:109‐20. [MEDLINE: ] - PubMed
Teplan 1998 {published data only}
    1. Teplan V, Schuck O, Bubenicek P, Mengerova O, Tesarova Z, Hajny J, et al. The effect of long‐term administration of a low‐protein diet on the metabolic status and progression of chronic renal failure: a multicentre study [abstract]. Nephrology Dialysis Transplantation 1998;13:820. [CENTRAL: CN‐00301551]
Williams 1991 {published data only}
    1. Williams P, Stevens ME, Fass G, Bone JM. A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. 10th International Congress of Nephrology; 1987 Jul 26‐31; London, UK. 1987:38.
    1. Williams PS, Stevens M, Fass G, Bone JM. A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation 1987;2(4):285.
    1. Williams PS, Stevens M, Irons L, Fass G, Bone JM. Failure of dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation 1990;5(8):674.
    1. Williams PS, Stevens ME. A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation 1987;2(5):401.
    1. Williams PS, Stevens ME, Fass G, Irons L, Bone JM. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine 1991;81(294):837‐55. [MEDLINE: ] - PubMed

References to studies excluded from this review

Bernard 1996 {published data only}
    1. Bernard S, Fouque D, Laville M, Zech P. Effects of low‐protein diet supplemented with ketoacids on plasma lipids in adult chronic renal failure. Mineral & Electrolyte Metabolism 1996;22(1‐3):143‐6. [MEDLINE: ] - PubMed
Bernhard 2001 {published data only}
    1. Bernhard J, Beaufrere B, Laville M, Fouque D. Adaptive response to a low‐protein diet in predialysis chronic renal failure patients. Journal of the American Society of Nephrology 2001;12(6):1249‐54. [MEDLINE: ] - PubMed
Choi 2012a {published data only}
    1. Choi HY, Lee YK, Kim BS, Park HC, Shin SK, Ha SK, et al. Effects of a keto/amino acid supplemented low protein diet on the delay of progressieve renal failure in chronic kidney disease [abstract no: 37]. Kidney Research & Clinical Practice 2012;31(2):A25. [EMBASE: 70814746]
Coresh 1994 {published data only}
    1. Coresh J, Walser M, Hill S. Long‐term outcome of treatment of chronic renal failure with a supplemented low protein diet [abstract]. Journal of the American Society of Nephrology 1994;5(3):489. - PubMed
Di Iorio 2009a {published data only}
    1. Iorio BR, Cucciniello E, Martino R, Frallicciardi A, Tortoriello R, Struzziero G. Acute and persistent antiproteinuric effect of a low‐protein diet in chronic kidney disease [Acuto e persistente effetto antiproteinurico della dieta ipoproteica artificiale nella malattia renale cronica]. Giornale Italiano di Nefrologia 2009;26(5):608‐15. [MEDLINE: ] - PubMed
Di Iorio 2012a {published data only}
    1. Iorio B, Micco L, Torraca S, Sirico ML, Russo L, Pota A, et al. Acute effects of very‐low‐protein diet on FGF23 levels: a randomized study.[Erratum appears in Clin J Am Soc Nephrol. 2012 Aug;7(8):1369]. Clinical Journal of the American Society of Nephrology: CJASN 2012;7(4):581‐7. [MEDLINE: ] - PubMed
    1. Marzocco S, Dal Piaz F, Micco L, Torraca S, Sirico ML, Tartaglia D, et al. Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease. Blood Purification 2013;35(1‐3):196‐201. [MEDLINE: ] - PubMed
DODE Study 2000 {published data only}
    1. Brunori G, Viola BF, Parrinello G, De Biase, Como G, Franco V, et al. Efficacy and safety of a very‐low‐protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. American Journal of Kidney Diseases 2007;49(5):569‐80. - PubMed
    1. Brunori G, Viola F, Zubani R, Biase V, Franco V, Cuoma D, et al. The DODE Study (diet or dialysis in elderly): interim analysis [abstract no: T501]. Nephrology Dialysis Transplantation 2003;18(Suppl 4):440.
    1. Maiorca R, Brunori G, Viola BF, Zubani R, Cancarini G, Parrinello G, et al. Diet or dialysis in the elderly? The DODE study: a prospective randomized multicenter trial. Journal of Nephrology 2000;13(4):267‐70. [MEDLINE: ] - PubMed
    1. Scalone L, Borghetti F, Brunori G, Viola BF, Brancati B, Sottini L, et al. Cost‐benefit analysis of supplemented very low‐protein diet versus dialysis in elderly CKD5 patients. Nephrology Dialysis Transplantation 2010;25(3):907‐13. [MEDLINE: ] - PubMed
El Nahas 1987 {published data only}
    1. Nahas AM, Meadows JH, Smith WG, Coles GA. The importance of timing of protein intake in chronic renal failure (CRF): a pilot study [abstract]. 10th International Congress of Nephrology; 1987 Jul 26‐31; London, UK. 1987:10.
ERIKA Study 2007 {published data only}
    1. Bellizzi V, Chiodini P, Nicola L, Minutolo R, Conte G, Iorio B. Long‐term effectiveness of very low protein diet in CKD: a pilot study [abstract no: SU‐PO1045]. Journal of the American Society of Nephrology 2007;18(Abstracts Issue):817A.
    1. Bellizzi V, Chiodini P, Nicola L, Minutolo R, Conte G, Iorio B. Long‐term outcome of very low protein diet in CKD: a pilot study [abstract no: 180]. Journal of Renal Nutrition 2008;18(3 Suppl 1):S46.
    1. Bellizzi V, Signoriello S, Minutolo R, Iorio B, Nazzaro P, Conte G, et al. Effect of very low‐protein diet versus standard low‐protein diet on renal death in patients with chronic kidney disease: A pragmatic, randomized, controlled, multicenter trial [abstract]. Nephrology Dialysis Transplantation 2015;30:iii476.
Garibotti 2018 {published data only}
    1. Garibotto G, Sofia A, Parodi EL, Ansaldo F, Bonanni A, Picciotto D. Effects of low protein, and supplemented very low–protein diets, on muscle protein turnover in patients with CKD. KI Reports 2018 Jan 11:[epub ahead of print]. [DOI: ] - PMC - PubMed
Garini 1992 {published data only}
    1. Garini G, Arisi L, Borrini A, Fiaccadori E, Guariglia A, Magnati G, et al. Adherence to dietetic treatment, the nutritional metabolic status and the progression of chronic kidney failure [Aderenza al trattamento dietetico, stato metabolico nutrizionale e progressione dell'insufficienza renale cronica]. Annali Italiani di Medicina Interna 1992;7(2):71‐7. [MEDLINE: ] - PubMed
Hecking 1980 {published data only}
    1. Hecking E, Andrzejewski L, Prellwitz W, Opferkuch W, Muller D. Double‐blind cross‐over study with oral alpha‐ketoacids in patients with chronic renal failure. American Journal of Clinical Nutrition 1980;33(7):1678‐81. [MEDLINE: ] - PubMed
Herselman 1995 {published data only}
    1. Herselman MG, Albertse EC, Lombard CJ, Swanepoel CR, Hough FS. Supplemented low‐protein diets‐‐are they superior in chronic renal failure?. South African Medical Journal 1995;85(5):361‐5. [MEDLINE: ] - PubMed
Ideura 2003 {published data only}
    1. Ideura T, Shimazui M, Tayama H, Inoue Y, Koiwa F, Morita H, et al. Protein intake more than 0.5g/kg body weight (BW)/Day is not effective in retarding the progression of chronic renal failure [abstract no: PUB062]. Journal of the American Society 2003;14(Nov):786A.
IRCCA Study 1990 {published data only}
    1. Forget D, Caranhac G, Quillot MJ. French multicentric trial (IRCCA) for testing a new ketoanalog and essential amino acid mixture in patients with chronic renal failure [abstract]. Kidney International 1988;36(Suppl 27):S300.
    1. Forget D, Caranhac G, Quillot MJ, Besnier MO. Compliance with very low protein diet and ketoanalogues in chronic renal failure. The French Multicentric Trial IRCCA. Contributions to Nephrology 1990;81:79‐86. [MEDLINE: ] - PubMed
Kopple 1982 {published data only}
    1. Kopple JD, Roberts CE, Grodstein GP, Shah GM, Winer RL, Davidson WP, et al. Adherence to low protein diets by chronically uremic patients [abstract]. Kidney International 1982;21(1):171.
    1. Roberts C, Kopple J, Grodstein G, Shah G, Winer R, Davidson W, et al. Acceptance of protein and amino acid diets by patients with chronic renal failure [abstract]. Kidney International 1983;24(Suppl 16):S‐350.
Laville 1994 {published data only}
    1. Fouque D, Bouc Y, Laville M, Zech P. Abnormal serum ingf‐binding proteins profile before and after a low‐protein diet (LPD) in CRF patients [abstract]. Journal of the American Society of Nephrology 1994;5(3):328.
    1. Laville M, Fouque D, Durozard D, Combarnous F, Baverel G, Zech P. Muscle energetics in renal failure: effects of a low‐protein diet (LPD) supplemented with ketoacids (KA) [abstract]. Journal of the American Society of Nephrology 1994;5(3):336.
Lim 2000 {published data only}
    1. Lim CS, Norashikin AB, Noor Aini MY, Zahara AM, Angl BB, Aparicio M, et al. The effect of very low protein supplemented by ketoamino acid versus low protein diet on progression of chronic renal failure [abstract]. 13th Asian Colloquium in Nephrology; 2000 Nov 23‐25; Bali, Indonesia. 2000:68.
    1. Lim CS, Tan SY, Aparicio M. A prospective study on the impact of very low protein diet supplemented by keto/amino acids vs low protein diet on rate of progression of chronic renal failure [abstract]. Journal of the American Society of Nephrology 2001;12(Program & Abstracts):221A.
    1. Noor Aini MY, Zahara AM, Norashikin AB, Lim CS, Ang BB, Aparicio M, et al. Dietary changes and nutritional status of chronic renal failure patients on very low protein diet supplemented by ketoamino acid versus low protein diet [abstract]. 13th Asian Colloquium in Nephrology; 2000 Nov 23‐25; Bali, Indonesia. 2000:140.
Maksic 2004 {published data only}
    1. Maksic D, Pavlovic G, Kostic‐Milosavljevic M, Mijuskovic Z, Radjen S, Bokonjic D, et al. Comparison of effects of low protein diet (LPD) and very low protein diet (VLPD) supplemented with essential and ketoanalogue amino acids on the progression of predialysis chronic renal failure [abstract]. ERA ‐ EDTA Congress; 2004; May 15‐18; Lisbon, Portugal. 2004:296.
Prakash 2004 {published data only}
    1. Prakash S, Pande D, Suresh K, Kulkarni H. Randomized double blind placebo controlled trial of ketoanalogues in retardation of chronic renal failure in tropics [abstract no: M416]. Nephrology Dialysis Transplantation 2003;18 Suppl(4):130. [CENTRAL: CN‐00447278]
    1. Prakash S, Pande DP, Sharma S, Sharma D, Bal CS, Kulkarni H. Randomized, double‐blind, placebo‐controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure. Journal of Renal Nutrition 2004;14(2):89‐96. [MEDLINE: ] - PubMed
Ren 2002 {published data only}
    1. Ren H, Chen N, Zao Q, Zhang D. Evaluation of the effect of low‐protein diet and combination diet with (alpha)‐ketoacid therapy in chronic renal failure. Shanghai Medical Journal 2002;25(11):671‐4. [CENTRAL: CN‐00461589]
    1. Ren H, Chen N, Zhao Q, Zhang D, Chen X, Zhang W. Evaluation of the effect of low‐protein diet and with a‐keto acid therapy in chronic renal failure [abstract no: PUB030]. Journal of the American Society of Nephrology 2003;14(Nov):779A.
Rosenberg 1987 {published data only}
    1. Rosenberg ME, Howe RB, Zanjani ED, Hostetter TH. The response of erythropoietin to dietary protein in human renal disease. Journal of Laboratory & Clinical Medicine 1989;113(6):735‐42. [MEDLINE: ] - PubMed
    1. Rosenberg ME, Swanson JE, Thomas BL, Hostetter TH. Glomerular and hormonal responses to dietary protein intake in human renal disease. American Journal of Physiology 1987;253(6 (Pt 2)):F1083‐90. [MEDLINE: ] - PubMed
    1. Rosenberg ME, Thomas BL, Swanson JE, Hostetter TH. Hormonal and glomerular responses to dietary protein intake in human renal disease [abstract]. Kidney International 1987;31(1):215. - PubMed
Sanchez 2010 {published data only}
    1. Sanchez C, Aranda P, Planells E, Galindo P, Perez de la Cruz A, Larrubia M, et al. Influence of low‐protein dietetic foods consumption on quality of life and levels of B vitamins and homocysteine in patients with chronic renal failure. Nutricion Hospitalaria 2010;25(2):238‐44. [MEDLINE: ] - PubMed
Teplan 2003 {published data only}
    1. Teplan V, Schuck O, Knotek A, Hajny J, Horackova M. Ketoacids and recombinant human erythro‐poietin may influence progression of chronic renal insufficiency: Czech multicentre study [abstract]. Nephrology Dialysis Transplantation 2001;16(6):A96.
    1. Teplan V, Schuck O, Knotek A, Hajny J, Horackova M, Kvapil M, et al. Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low‐protein diet: Czech multicenter study. American Journal of Kidney Diseases 2003;41(3 Suppl 1):S26‐30. [MEDLINE: ] - PubMed
    1. Teplan V, Schuck O, Knotek A, Hajny J, Surel S. Metabolic effect of erythropoietin and keto acids in CRF: Czech multicentre study [abstract]. Nutrition 2003;19(4):399. - PubMed
    1. Teplan V, Schuck O, Poledne R, Mengerova O. The influence of erythropoietin (r‐Hu EPO) and keto amino acids (KA) on lipid metabolism and renal function tests in chronic renal failure (CRF) [abstract no: A3094]. Journal of the American Society of Nephrology 1996;7(9):1865.
    1. Teplan V, Schuck O, et al. Erythropoietin (r‐Hu EPO) and keto amino acids (KA): an effect on lipid metabolism in predialysis [abstract]. Nephrology Dialysis Transplantation 1996;11(6):A263.
Teplan 2006 {published data only}
    1. Teplan V, Mareckova O, Vyhnankova I, Valkovsky I, Lopatnik M, Racek J, et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial [Asymetricky dimethylarginin a pentosidin u nemocnych s chronickym onemocnenim ledvin a obezitou: Randomizovana kontrolovana studie]. Aktuality v Nefrologii 2008;14(4):185‐90. [EMBASE: 2009017142]
    1. Teplan V, Schuck O, Hanzal V, Hajny J, Horackova M, Ryba M, et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double‐blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi 2006;52(6):571‐6. [MEDLINE: ] - PubMed
    1. Teplan V, Schuck O, Racek J, Mareckova O, Stollova M, Hanzal V, et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low‐protein diet supplemented with keto‐amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift 2008;120(15‐16):478‐85. [MEDLINE: ] - PubMed
Ursea 2002 {published data only}
    1. Ursea N, Garneata L, Hildegard Stancu S. Effects of a hypoproteic diet supplemented with ketoanalogues in chronic renal failure [abstract no: T173]. Nephrology Dialysis Transplantation 2002;17(Suppl 12):237.
Vujic 1987 {published data only}
    1. Vujic D, Djukanovic L. The effect of low protein diet on the progression of chronic renal failure [abstract]. 24th Annual Congress. EDTA‐ERA; 1987 Oct 25‐29; West Berlin, West Germany. 1987:69.
Zhang 2015 {published data only}
    1. Zhang MM, Zhao Y, Zhu YL. Effect of individualized low‐protein diet intervention on renal function of patients with chronic kidney disease. Chung‐Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae 2015;37(4):384‐91. [MEDLINE: ] - PubMed
Zhang 2016b {published data only}
    1. Zhang J, Xie H, Fang M, Wang K, Chen J, Sun W, et al. Keto‐supplemented low protein diet: a valid therapeutic approach for patients with steroid‐resistant proteinuria during early‐stage chronic kidney disease. Journal of Nutrition, Health & Aging 2016;20(4):420‐7. [MEDLINE: ] - PubMed

References to ongoing studies

NCT01418508 {published data only}
    1. Li X, Chen L. Effects of low protein diet supplemented keto‐/amino acid in preventing the progression of chronic kidney disease(CKD)‐ ELPD study (ELPD‐CKD). www.clinicaltrials.gov/ct2/show/NCT01418508 (first received 15 August 2011).

Additional references

Bellizzi 2016
    1. Bellizzi V, Cupisti A, Locatelli F, Bolasco P, Brunori G, Cancarini G, et al. Low‐protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrology 2016;17(1):77. [MEDLINE: ] - PMC - PubMed
GRADE 2008
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924‐6. [MEDLINE: ] - PMC - PubMed
GRADE 2011a
    1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, BrozekJ, et al. GRADE Guidelines:1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94. [MEDLINE: ] - PubMed
GRADE 2011b
    1. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE Guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401‐6. [MEDLINE: ] - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. [MEDLINE: ] - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hostetter 1986
    1. Hostetter TH, Meyer TW, Rennke HG, Brenner BM. Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney International 1986;30(4):509‐17. [MEDLINE: ] - PubMed
Johnson 2006
    1. Johnson DW. Dietary protein restriction as a treatment for slowing chronic kidney disease progression: the case against. Nephrology 2006;11(1):58‐62. [MEDLINE: ] - PubMed
Johnson 2013
    1. Johnson DW, Atai E, Chan M, Poon RK, Scott C, Toussaint ND, et al. KHA‐CARI Guideline: Early chronic kidney disease: Detection, prevention and management. Nephrology 2013;18(5):340‐50. [MEDLINE: ] - PubMed
Kalantar‐ Zadeh 2016
    1. Kalantar‐Zadeh K, Moore LW, Tortorici AR, Chou JA, St‐ Jules DE, Aoun A, et al. North American Experience with low protein diet for non dialysis dependent chronic kidney disease. BMC Nephrology 2016;17(1):90. [MEDLINE: ] - PMC - PubMed
Kalantar‐Zadeh 2017
    1. Kalantar‐Zadeh K, Fouque D. Nutritional management of chronic kidney disease. New England Journal of Medicine 2017;377(18):1765‐76. [MEDLINE: ] - PubMed
Kasiske 1998
    1. Kasiske BL, Lakatua JD, Ma JZ, Louis TA. A meta‐analysis of the effects of dietary protein restriction on the rate of decline in renal function. American Journal of Kidney Diseases 1998;31(6):954‐61. [MEDLINE: ] - PubMed
KDIGO 2012
    1. Levin A, Stevens PE, Bilous RW, Coresh J, Francisco AL, Jong PE, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international ‐ Supplement 2013;3(1):1‐150. [EMBASE: 369856107]
Mandayam 2006
    1. Mandayam S, Mitch WE. Dietary protein restriction benefits patients with chronic kidney disease. Nephrology 2006;11(1):53‐7. [MEDLINE: ] - PubMed
Maroni 1985
    1. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney International 1985;27(1):58‐65. [MEDLINE: ] - PubMed
Matshushita 2010
    1. Chronic Kidney Disease Prognosis Consortium, Matshushita K, Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all‐cause and cardiovascular mortality in general population cohorts: a collaborative meta‐analysis. Lancet 2010;375(9731):2073‐81. [MEDLINE: ] - PMC - PubMed
Mitch 2016
    1. Mitch WE, Remuzzi G. Diets for patients with chronic kidney disease, should we reconsider?. BMC Nephrology 2016;17(1):80. [MEDLINE: ] - PMC - PubMed
Pedrini 1996
    1. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta‐analysis. Annals of Internal Medicine 1996;124(7):627‐32. [MEDLINE: ] - PubMed
Piccoli 2016
    1. Piccoli GB, Capizzi I, Vigotti FN, Leone F, D'Alessandro C, Giuffrida D, et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary‐alternative medicines?. BMC Nephrology 2016;17(1):76. [MEDLINE: ] - PMC - PubMed
Schünemann 2011a
    1. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Schünemann 2011b
    1. Schünemann HJ, Oxman AD, Higgins JP, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Wright 2011
    1. Wright M, Jones C. Renal Association clinical practice guideline on nutrition in CKD. Nephron 2011;118 Suppl 1:153‐64. [MEDLINE: ] - PubMed

References to other published versions of this review

Fouque 2000a
    1. Fouque D, Wang P, Laville M, Boissel JP. Low protein diets delay end‐stage renal disease in non‐diabetic adults with chronic renal failure. Nephrology Dialysis Transplantation 2000;15(12):1986‐92. [MEDLINE: ] - PubMed
Fouque 2000b
    1. Fouque D, Wang PH, Laville M, Boissel JP. Low protein diets for chronic renal failure in non diabetic adults. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD001892] - DOI - PubMed
Fouque 2006
    1. Fouque D, Laville M, Boissel J‐P. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD001892.pub2] - DOI - PubMed
Fouque 2009
    1. Fouque D, Laville M. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD001892.pub3] - DOI - PubMed

Publication types

MeSH terms